Research programme: HBV cccDNA epigenetic modifiers - Tune Therapeutics
Latest Information Update: 04 Dec 2023
At a glance
- Originator Tune Therapeutics
- Class Antivirals
- Mechanism of Action Gene expression modulators; Genetic transcription modulators; Hepatitis B virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis B